Hasta la próxima

Auto reproducción

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

0 vistas • 07/04/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Earn CME for related activities: https://www.naccme.com/oln

This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.

© 2018 NACCME, an HMP Company

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción